Quipt Home Medical Shareholder Pressures Board to Consider Sale
Shareholder's Call for Sale: Bradley L. Radoff, a shareholder owning about 4.9% of Quipt Home Medical, is urging the company to pursue a sale after it rejected previous acquisition interest.
Criticism of Board's Actions: Radoff criticized the Board for poor execution and shareholder value destruction, particularly after they awarded insiders 6% of the company despite receiving credible acquisition offers.
Previous Acquisition Offer: In August, Quipt Home Medical received an offer from Forager Capital to buy all outstanding shares at $3.10 per share in cash.
Voting Intentions: Radoff plans to vote against all incumbent directors at the 2026 annual meeting if the company's current situation does not change.
Get Free Real-Time Notifications for Any Stock
Analyst Views on CA
No data
About the author
Lux Metals increases private placement to $3.5 million
Private Placement Increase: Lux Metals has increased its private placement from 12.5 million units to 17.5 million units due to strong investor demand, aiming for total gross proceeds of up to $3.5 million.
Unit Composition: Each unit will consist of one common share and one transferable share purchase warrant, with warrants exercisable for an additional share at $0.40 each for two years.
Use of Proceeds: The funds raised will be allocated for exploration costs and general working capital.
Company Information: Additional financial information and ratings for Lux Metals Corp. can be found on Seeking Alpha.
Copper Giant increases private placement to $12 million
Private Placement Increase: Copper Giant Resources has raised the size of its non-brokered private placement from $10 million to $12 million.
Unit Details: The company plans to issue up to 30 million units at C$0.40 each, with each unit consisting of one common share and one-half of a warrant.
Warrant Terms: Each whole warrant will be exercisable at C$0.60 per share for a period of 36 months from the closing date.
Use of Proceeds: The funds raised will be used for working capital and general corporate purposes, pending approval from the TSX Venture Exchange.